These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 37468831)

  • 1. Prevalence of increased risk of type 2 diabetes in general practice: a cross-sectional study in Norway.
    Riise HKR; Graue M; Igland J; Birkeland KI; Kolltveit BH
    BMC Prim Care; 2023 Jul; 24(1):151. PubMed ID: 37468831
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patient activation in adults attending appointments in general practice: a cross-sectional study.
    Hernar I; Graue M; Igland J; Richards DA; Riise HKR; Haugstvedt A; Kolltveit BH
    BMC Prim Care; 2023 Jul; 24(1):144. PubMed ID: 37430197
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ethnicity is an independent risk indicator when estimating diabetes risk with FINDRISC scores: a cross sectional study comparing immigrants from the Middle East and native Swedes.
    Bennet L; Groop L; Lindblad U; Agardh CD; Franks PW
    Prim Care Diabetes; 2014 Oct; 8(3):231-8. PubMed ID: 24472421
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the Finnish Diabetes Risk Score (FINDRISC) for diabetes screening in Kayseri, Turkey.
    Atayoglu AT; Inanc N; Başmisirli E; Çapar AG
    Prim Care Diabetes; 2020 Oct; 14(5):488-493. PubMed ID: 32029385
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Shifting from glucose diagnosis to the new HbA1c diagnosis reduces the capability of the Finnish Diabetes Risk Score (FINDRISC) to screen for glucose abnormalities within a real-life primary healthcare preventive strategy.
    Costa B; Barrio F; Piñol JL; Cabré JJ; Mundet X; Sagarra R; Salas-Salvadó J; Solà-Morales O;
    BMC Med; 2013 Feb; 11():45. PubMed ID: 23438147
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validity of the FINDRISC as a prediction tool for diabetes in a contemporary Norwegian population: a 10-year follow-up of the HUNT study.
    Jølle A; Midthjell K; Holmen J; Carlsen SM; Tuomilehto J; Bjørngaard JH; Åsvold BO
    BMJ Open Diabetes Res Care; 2019; 7(1):e000769. PubMed ID: 31803483
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does Future Diabetes Risk Impair Current Quality of Life? A Cross-Sectional Study of Health-Related Quality of Life in Relation to the Finnish Diabetes Risk Score (FINDRISC).
    Väätäinen S; Cederberg H; Roine R; Keinänen-Kiukaanniemi S; Saramies J; Uusitalo H; Tuomilehto J; Martikainen J
    PLoS One; 2016; 11(2):e0147898. PubMed ID: 26840374
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Performance of the Finnish Diabetes Risk Score and a Simplified Finnish Diabetes Risk Score in a Community-Based, Cross-Sectional Programme for Screening of Undiagnosed Type 2 Diabetes Mellitus and Dysglycaemia in Madrid, Spain: The SPREDIA-2 Study.
    Salinero-Fort MA; Burgos-Lunar C; Lahoz C; Mostaza JM; Abánades-Herranz JC; Laguna-Cuesta F; Estirado-de Cabo E; García-Iglesias F; González-Alegre T; Fernández-Puntero B; Montesano-Sánchez L; Vicent-López D; Cornejo-Del Río V; Fernández-García PJ; Sánchez-Arroyo V; Sabín-Rodríguez C; López-López S; Patrón-Barandio P; Gómez-Campelo P;
    PLoS One; 2016; 11(7):e0158489. PubMed ID: 27441722
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Large scale application of the Finnish diabetes risk score in Latin American and Caribbean populations: a descriptive study.
    Nieto-Martinez R; Barengo NC; Restrepo M; Grinspan A; Assefi A; Mechanick JI
    Front Endocrinol (Lausanne); 2023; 14():1188784. PubMed ID: 37435487
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Using HbA1c measurements and the Finnish Diabetes Risk Score to identify undiagnosed individuals and those at risk of diabetes in primary care.
    Arnardóttir E; Sigurðardóttir ÁK; Graue M; Kolltveit BH; Skinner T
    BMC Public Health; 2023 Jan; 23(1):211. PubMed ID: 36721135
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluating FINDRISC as a screening tool for type 2 diabetes among overweight adults in the PREVIEW:NZ cohort.
    Silvestre MP; Jiang Y; Volkova K; Chisholm H; Lee W; Poppitt SD
    Prim Care Diabetes; 2017 Dec; 11(6):561-569. PubMed ID: 28801192
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neck Circumference and its Correlation to Other Anthropometric Parameters and Finnish Diabetes Risk Score (FINDRISC).
    Volaco A; Martins CM; Soares JQ; Cavalcanti AM; Moyses ST; Filho RP; Baena CP; Precoma DB
    Curr Diabetes Rev; 2018; 14(5):464-471. PubMed ID: 28969558
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the Finnish Diabetes Risk Score (FINDRISC) for diabetes screening in occupational health care.
    Vandersmissen GJ; Godderis L
    Int J Occup Med Environ Health; 2015; 28(3):587-91. PubMed ID: 26190733
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic accuracy of the Finnish Diabetes Risk Score (FINDRISC) for undiagnosed T2DM in Peruvian population.
    Bernabe-Ortiz A; Perel P; Miranda JJ; Smeeth L
    Prim Care Diabetes; 2018 Dec; 12(6):517-525. PubMed ID: 30131300
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prediction of type 2 diabetes mellitus onset using logistic regression-based scorecards.
    Edlitz Y; Segal E
    Elife; 2022 Jun; 11():. PubMed ID: 35731045
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Two-stage, school and community-based population screening successfully identifies individuals and families at high-risk for type 2 diabetes: the Feel4Diabetes-study.
    Manios Y; Mavrogianni C; Lambrinou CP; Cardon G; Lindström J; Iotova V; Tankova T; Civeira F; Kivelä J; Jancsó Z; Shadid S; Tsochev K; Mateo-Gallego R; Radó S; Dafoulas G; Makrilakis K; Androutsos O;
    BMC Endocr Disord; 2020 Mar; 20(Suppl 1):12. PubMed ID: 32164646
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A more simplified Finnish diabetes risk score for opportunistic screening of undiagnosed type 2 diabetes in a German population with a family history of the metabolic syndrome.
    Li J; Bergmann A; Reimann M; Bornstein SR; Schwarz PE
    Horm Metab Res; 2009 Feb; 41(2):98-103. PubMed ID: 18975253
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of the modified FINDRISC to identify individuals at high risk for diabetes among middle-aged white and black ARIC study participants.
    Kulkarni M; Foraker RE; McNeill AM; Girman C; Golden SH; Rosamond WD; Duncan B; Schmidt MI; Tuomilehto J
    Diabetes Obes Metab; 2017 Sep; 19(9):1260-1266. PubMed ID: 28321981
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.